Boris Trautmann
Directeur Général chez IDT Biologika GmbH
Profil
Boris Trautmann is currently the Co-Managing Director at IDT Biologika GmbH.
He previously worked as the Co-Managing Director at Treofan Holdings GmbH.
Postes actifs de Boris Trautmann
Sociétés | Poste | Début |
---|---|---|
IDT Biologika GmbH
IDT Biologika GmbH Pharmaceuticals: MajorHealth Technology IDT Biologika GmbH manufactures and distributes vaccines and biopharmaceuticals for the protection of human and animal health. The firm offers development services and manufacturing facilities for clinical phase I to III as well as commercial supplies for viral and bacterial human and animal health vaccines. The company was founded on July 1, 1921 and is headquartered in Dessau-Rosslau, Germany. | Directeur Général | - |
Anciens postes connus de Boris Trautmann
Sociétés | Poste | Fin |
---|---|---|
Treofan Holdings GmbH
Treofan Holdings GmbH Containers/PackagingProcess Industries Treofan Holdings GmbH develops, produces, and markets polypropylene films. These are used in the food packaging industry. It offers products for packaging, label, and tobacco film applications, as well as films for electronic devices such as capacitors. The company was founded on July 18, 2002 and is headquartered in Raunheim, Germany. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Treofan Holdings GmbH
Treofan Holdings GmbH Containers/PackagingProcess Industries Treofan Holdings GmbH develops, produces, and markets polypropylene films. These are used in the food packaging industry. It offers products for packaging, label, and tobacco film applications, as well as films for electronic devices such as capacitors. The company was founded on July 18, 2002 and is headquartered in Raunheim, Germany. | Process Industries |
IDT Biologika GmbH
IDT Biologika GmbH Pharmaceuticals: MajorHealth Technology IDT Biologika GmbH manufactures and distributes vaccines and biopharmaceuticals for the protection of human and animal health. The firm offers development services and manufacturing facilities for clinical phase I to III as well as commercial supplies for viral and bacterial human and animal health vaccines. The company was founded on July 1, 1921 and is headquartered in Dessau-Rosslau, Germany. | Health Technology |